XML 56 R33.htm IDEA: XBRL DOCUMENT v3.24.2.u1

Accounts Payable and Accrued Liabilities (Tables)

6 Months Ended

Jun. 30, 2024

Payables and Accruals [Abstract]

Schedule of Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consist of the following (in thousands):

			As of
			June 30, 2024						December 31, 2023
Accounts payable and other accrued operating expenses			$	51,363					$	65,393
Accrued clinical trial expenses			22,581						23,711
Accrued professional fees			16,114						13,885
Accrued technical operation expenses			11,097						9,187
Accrued compensation and employee related costs			42,198						48,933
Accrued royalty and milestones payable			7,288						5,674
Accrued interest payable			2,175						2,175
Revenue Interest Payments payable			3,613						3,347
Accrued sales allowances and related costs			14,479						10,937
Accrued France ATU reimbursement payable			17,188						14,685
Deferred and contingent consideration			81,600						6,700
Accrued milestone payment to AstraZeneca			12,500						—
Other accrued liabilities			8,648						10,360
			$	290,844					$	214,987

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the components of accrued liabilities.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration